IN8bio, Inc.
INAB
$0.1449
$0.01219.11%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -27.43M | -30.44M | -31.88M | -31.96M | -31.04M |
| Total Depreciation and Amortization | 2.69M | 2.66M | 2.58M | 2.54M | 2.54M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.64M | 5.05M | 5.47M | 4.90M | 4.75M |
| Change in Net Operating Assets | 745.00K | -1.41M | -1.15M | -55.00K | -70.00K |
| Cash from Operations | -19.35M | -24.15M | -24.97M | -24.57M | -23.82M |
| Capital Expenditure | -116.00K | -187.00K | -226.00K | -303.00K | -242.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -116.00K | -187.00K | -226.00K | -303.00K | -242.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -831.00K | -794.00K | -748.00K | -771.00K | -811.00K |
| Issuance of Common Stock | 19.19M | 15.07M | 17.37M | 18.97M | 27.12M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -89.00K | -270.00K | -89.00K | -89.00K |
| Cash from Financing | 18.35M | 14.18M | 16.35M | 18.11M | 26.22M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.11M | -10.15M | -8.85M | -6.77M | 2.16M |